• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对计数数据中的过离散和马尔可夫特征进行建模。

Modelling overdispersion and Markovian features in count data.

机构信息

Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Pamplona, Spain.

出版信息

J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):461-77. doi: 10.1007/s10928-009-9131-y. Epub 2009 Oct 2.

DOI:10.1007/s10928-009-9131-y
PMID:19798550
Abstract

The number of counts (events) per unit of time is a discrete response variable that is generally analyzed with the Poisson distribution (PS) model. The PS model makes two assumptions: the mean number of counts (lambda) is assumed equal to the variance, and counts occurring in non-overlapping intervals are assumed independent. However, many counting outcomes show greater variability than predicted by the PS model, a phenomenon called overdispersion. The purpose of this study was to implement and explore, in the population context, different distribution models accounting for overdispersion and Markov patterns in the analysis of count data. Daily seizures count data obtained from 551 subjects during the 12-week screening phase of a double-blind, placebo-controlled, parallel-group multicenter study performed in epileptic patients with medically refractory partial seizures, were used in the current investigation. The following distribution models were fitted to the data: PS, Zero-Inflated PS (ZIP), Negative Binomial (NB), and Zero-Inflated Negative Binomial (ZINB) models. Markovian features were introduced estimating different lambdas and overdispersion parameters depending on whether the previous day was a seizure or a non-seizure day. All analyses were performed with NONMEM VI. All models were successfully implemented and all overdispersed models improved the fit with respect to the PS model. The NB model resulted in the best description of the data. The inclusion of Markovian features in lambda and in the overdispersion parameter improved the fit significantly (P < 0.001). The plot of the variance versus mean daily seizure count profiles, and the number of transitions, are suggested as model performance tools reflecting the capability to handle overdispersion and Markovian features, respectively.

摘要

单位时间内的计数(事件)数量是一个离散的响应变量,通常使用泊松分布(PS)模型进行分析。PS 模型做出了两个假设:计数的平均值(lambda)被假设等于方差,并且在非重叠的时间间隔内发生的计数被假设是独立的。然而,许多计数结果显示出比 PS 模型预测的更大的可变性,这种现象称为过离散。本研究的目的是在人群背景下实施和探索不同的分布模型,这些模型考虑了计数数据分析中的过离散和马尔可夫模式。本研究使用了在患有医学难治性部分性癫痫发作的患者中进行的双盲、安慰剂对照、平行组多中心研究的 12 周筛选阶段中从 551 名受试者获得的每日发作计数数据。对数据进行了 PS、零膨胀 PS(ZIP)、负二项式(NB)和零膨胀负二项式(ZINB)模型拟合。引入了马尔可夫特征,根据前一天是发作日还是非发作日,估计不同的 lambda 和过离散参数。所有分析均使用 NONMEM VI 进行。所有模型均成功实施,所有过离散模型均改善了 PS 模型的拟合度。NB 模型对数据的描述最佳。在 lambda 和过离散参数中包含马尔可夫特征显著改善了拟合度(P<0.001)。方差与每日发作计数的均值图,以及跃迁的数量,被建议作为模型性能工具,分别反映了处理过离散和马尔可夫特征的能力。

相似文献

1
Modelling overdispersion and Markovian features in count data.对计数数据中的过离散和马尔可夫特征进行建模。
J Pharmacokinet Pharmacodyn. 2009 Oct;36(5):461-77. doi: 10.1007/s10928-009-9131-y. Epub 2009 Oct 2.
2
On performance of parametric and distribution-free models for zero-inflated and over-dispersed count responses.关于零膨胀和过度分散计数响应的参数模型和非参数模型的性能。
Stat Med. 2015 Oct 30;34(24):3235-45. doi: 10.1002/sim.6560. Epub 2015 Jun 15.
3
A comparison of statistical methods for modeling count data with an application to hospital length of stay.一种用于对计数数据建模的统计方法比较及其在住院时间中的应用。
BMC Med Res Methodol. 2022 Aug 4;22(1):211. doi: 10.1186/s12874-022-01685-8.
4
Performance in population models for count data, part I: maximum likelihood approximations.计数数据总体模型中的性能,第一部分:最大似然近似。
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66. doi: 10.1007/s10928-009-9126-8. Epub 2009 Aug 4.
5
Analyzing hospitalization data: potential limitations of Poisson regression.分析住院数据:泊松回归的潜在局限性
Nephrol Dial Transplant. 2015 Aug;30(8):1244-9. doi: 10.1093/ndt/gfv071. Epub 2015 Mar 25.
6
Multilevel modeling in single-case studies with zero-inflated and overdispersed count data.零膨胀和过离散计数数据的单病例研究中的多层次建模。
Behav Res Methods. 2024 Apr;56(4):2765-2781. doi: 10.3758/s13428-024-02359-7. Epub 2024 Feb 21.
7
Marginalized multilevel hurdle and zero-inflated models for overdispersed and correlated count data with excess zeros.用于具有过多零值的过度分散和相关计数数据的边缘化多级障碍模型和零膨胀模型。
Stat Med. 2014 Nov 10;33(25):4402-19. doi: 10.1002/sim.6237. Epub 2014 Jun 23.
8
Statistical modelling of falls count data with excess zeros.基于过零数据的跌倒计数资料的统计建模。
Inj Prev. 2011 Aug;17(4):266-70. doi: 10.1136/ip.2011.031740. Epub 2011 Jun 8.
9
Models for analyzing zero-inflated and overdispersed count data: an application to cigarette and marijuana use.用于分析零膨胀和过度分散计数数据的模型:在香烟和大麻使用中的应用。
Nicotine Tob Res. 2018 Apr 18;22(8):1390-8. doi: 10.1093/ntr/nty072.
10
Statistical modelling for falls count data.用于跌倒计数数据的统计建模。
Accid Anal Prev. 2010 Mar;42(2):384-92. doi: 10.1016/j.aap.2009.08.018. Epub 2009 Oct 1.

引用本文的文献

1
A tutorial on pharmacometric Markov models.药物计量马尔可夫模型教程。
CPT Pharmacometrics Syst Pharmacol. 2025 Feb;14(2):197-216. doi: 10.1002/psp4.13278. Epub 2024 Dec 13.
2
A Bayesian model for predicting monthly fire frequency in Kenya.一种用于预测肯尼亚月度火灾发生频率的贝叶斯模型。
PLoS One. 2024 Jan 25;19(1):e0291800. doi: 10.1371/journal.pone.0291800. eCollection 2024.
3
Semimechanistic models to relate noxious stimulation, movement, and pupillary dilation responses in the presence of opioids.在阿片类药物存在的情况下,将有害刺激、运动和瞳孔扩张反应联系起来的半机械模型。

本文引用的文献

1
Exposure-response analysis for spontaneously reported dizziness in pregabalin-treated patient with generalized anxiety disorder.普瑞巴林治疗广泛性焦虑障碍患者自发报告头晕的暴露-反应分析。
Clin Pharmacol Ther. 2008 Jul;84(1):127-35. doi: 10.1038/sj.clpt.6100491. Epub 2008 Feb 6.
2
A demonstration of modeling count data with an application to physical activity.计数数据建模的演示及其在身体活动中的应用
Epidemiol Perspect Innov. 2006 Mar 21;3:3. doi: 10.1186/1742-5573-3-3.
3
Modelling a spontaneously reported side effect by use of a Markov mixed-effects model.
CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):581-593. doi: 10.1002/psp4.12729. Epub 2021 Nov 18.
4
Natural variability in seizure frequency: Implications for trials and placebo.发作频率的自然变异性:对试验和安慰剂的影响。
Epilepsy Res. 2020 May;162:106306. doi: 10.1016/j.eplepsyres.2020.106306. Epub 2020 Mar 6.
5
Population pharmacokinetics-pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex.口服依维莫司治疗与结节性硬化症相关癫痫患者的群体药代动力学-药效学研究。
J Pharmacokinet Pharmacodyn. 2018 Oct;45(5):707-719. doi: 10.1007/s10928-018-9600-2. Epub 2018 Jul 10.
6
An automated sampling importance resampling procedure for estimating parameter uncertainty.一种用于估计参数不确定性的自动采样重要性重采样程序。
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):509-520. doi: 10.1007/s10928-017-9542-0. Epub 2017 Sep 8.
7
Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.从成人外推到局灶性癫痫儿童的布瓦加坦暴露-反应模型。
Clin Pharmacokinet. 2018 Jul;57(7):843-854. doi: 10.1007/s40262-017-0597-2.
8
Pharmacometrics models with hidden Markovian dynamics.具有隐马尔可夫动态的药物代谢动力学模型。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):91-105. doi: 10.1007/s10928-017-9541-1. Epub 2017 Aug 31.
9
PharmML in Action: an Interoperable Language for Modeling and Simulation.PharmML 在行动:一种用于建模和模拟的可互操作语言。
CPT Pharmacometrics Syst Pharmacol. 2017 Oct;6(10):651-665. doi: 10.1002/psp4.12213. Epub 2017 Sep 15.
10
A big data approach to the development of mixed-effects models for seizure count data.一种用于癫痫发作计数数据的混合效应模型开发的大数据方法。
Epilepsia. 2017 May;58(5):835-844. doi: 10.1111/epi.13727. Epub 2017 Mar 30.
使用马尔可夫混合效应模型对自发报告的副作用进行建模。
J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):261-81. doi: 10.1007/s10928-005-0021-7. Epub 2005 Nov 7.
4
Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat.替加宾与拉莫三嗪联合应用对大鼠抗惊厥作用的药效学分析
Epilepsia. 2004 May;45(5):424-35. doi: 10.1111/j.0013-9580.2004.50503.x.
5
Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.普瑞巴林添加治疗难治性部分性癫痫患者的暴露-反应分析。
Clin Pharmacol Ther. 2003 Jun;73(6):491-505. doi: 10.1016/S0009-9236(03)00049-3.
6
A population pharmacokinetic-pharmacodynamic analysis of repeated measures time-to-event pharmacodynamic responses: the antiemetic effect of ondansetron.重复测量事件发生时间药效学反应的群体药代动力学-药效学分析:昂丹司琼的止吐作用
J Pharmacokinet Biopharm. 1999 Dec;27(6):625-44. doi: 10.1023/a:1020930626404.
7
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.一个关于替马西泮对睡眠影响的药效学马尔可夫混合效应模型。
Clin Pharmacol Ther. 2000 Aug;68(2):175-88. doi: 10.1067/mcp.2000.108669.
8
Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.治疗指数的定量表征:应用混合效应模型评估奥昔布宁的剂量-疗效和剂量-副作用关系。
Clin Pharmacol Ther. 1999 Jun;65(6):672-84. doi: 10.1016/S0009-9236(99)90089-9.